Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction-Reference-Cited by-全球学者库

Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction

Published:2017-07-12 Issue:12 Volume:21 Page:3552-3564
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Chiang Yao-Chang¹²,Wang Ruey-Yun¹³,Huang Chieh-Liang¹⁴,Chen Shue-Hwa⁵,Ho Wen-Jing⁵,Lane Hsien-Yuan¹⁴⁶,Ho Ing-Kang¹,Yang Hwei-Ting⁷,Ma Wen-Lung¹⁴⁵⁸^ORCID

Affiliation:

1. Center for Drug Abuse and Addiction; Brain Disease Research Center; China Medical University; Taichung Taiwan

2. Department of Nursing; Division of Basic Medical Sciences; Chang Gong University of Science and Technology; Chiayi County Taiwan

3. Department of Public Health; China Medical University; Taichung Taiwan

4. Department of Psychiatry; China Medical University Hospital; Taichung Taiwan

5. Sex Hormone Research Center; China Medical University Hospital; Taichung Taiwan

6. Department of Nutrition; China Medical University; Taichung Taiwan

7. Graduate Institution of Clinical Medical Science; China Medical University; Taichung Taiwan

8. Department of Nursing; Asia University; Taichung Taiwan

Funder

National Core Facility Program for Biotechnology

Taiwan Ministry Of Sciences and Technology

Taiwan National Health Research Institute

Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcmm.13266/fullpdf

Reference55 articles.

1. A systematic review of combination step III opioid therapy in cancer pain: an EPCRC opioid guideline project;Fallon;Palliat Med,2011

2. Tolerance and addiction liability of 6-dimethylamino-4-4-diphenylheptanone-3 (methadon);Isbell;J Am Med Assoc,1947

3. Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine;Ling;J Psychoactive Drugs,1994

4. Neurophysiology of pain and pain modulation;Fields;Am J Med,1984

5. Methadone and buprenorphine treatment during pregnancy: what are the effects on infants?;Pritham;Nurs Womens Health,2007

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estradiol and Mu opioid-mediated reward: The role of estrogen receptors in opioid use;Addiction Neuroscience;2023-12

2. Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement;Neuropharmacology;2023-11

3. Interaction of gonadal hormones, dopaminergic system, and epigenetic regulation in the generation of sex differences in substance use disorders: A systematic review;Frontiers in Neuroendocrinology;2023-10

4. Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats;Frontiers in Pharmacology;2023-04-27

5. Special aspects in the pharmacotherapeutic treatment of forensically hospitalized female patients;Forensische Psychiatrie, Psychologie, Kriminologie;2023-04-21